The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma
The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma
复制标题
结直肠腺癌中IGF-II与Bcl-2表达的相关性
DOI:
10.1007/s12032-011-9881-4
复制
发表时间:
2012-06
期刊:
影响因子:
--
通讯作者:
陈元
中科院分区:
文献类型:
--
作者:
张明生;胡爱华;邱红;熊慧华;陈元
Our aim for this study was to investigate the correlation and clinical significance between the expression of IGF-II and Bcl-2 in colorectal adenocarcinoma, especially in terms of the metastasis of colorectal adenocarcinoma. Sixty paraffin embedded samples of colorectal adenocarcinoma were selected, and fifteen normal colorectal tissues were used as controls. IGF-II mRNA was detected using in situ hybridization, and the expression of Bcl-2 along with the proliferating cell nuclear antigen (PCNA) protein was detected through immunohistochemistry. The TUNEL assay was used to detect apoptosis. Specimens with a positive cell ratio less than 30% were defined as negative. The levels of IGF-II mRNA and the Bcl-2 protein were significantly higher in colorectal adenocarcinoma (39.64 ± 7.38% and 30.74 ± 7.22%, respectively) than in normal colorectal tissues (22.56 ± 4.21% and 12.17 ± 1.94%, respectively) (P< 0.01). The levels were related to Dukes′ stage and lymph node metastases, but were unrelated to patient age, gender, tumor site, tumor size, and tumor differentiation. Also, a negative correlation was observed between IGF-II mRNA and Bcl-2 protein (P< 0.05) during Dukes′ stages. In addition, a positive correlation between IGF-II mRNA and PCNA or apoptosis, as well as a negative correlation between Bcl-2 and apoptosis were observed (P< 0.01). There was no correlation between Bcl-2 and PCNA (P> 0.05). The patients detected as IGF-II mRNA (+) and Bcl-2 (−) showed the worst prognosis. The expression of IGF-II and Bcl-2 was correlated with the clinical manifestation of colorectal adenocarcinoma; thus, the assessment of both IGF-II and Bcl-2’s status will provide important information regarding the diagnosis and prognosis of colorectal adenocarcinoma.
登录
查看更多内容
影响因子:
56.9
作者:
TSUJIMOTO, Y;FINGER, LR;CROCE, CM
通讯作者:
CROCE, CM
影响因子:
64.8
作者:
Geballe, TR;Oka, T
通讯作者:
Oka, T
影响因子:
3.5
作者:
Kawamoto, K;Onodera, H;Imamura, M
通讯作者:
Imamura, M
DOI:
10.1016/0006-291x(87)91635-4
发表时间:
1987-11
影响因子:
3.1
作者:
Quynh T. Rohlik;David J. Adams;Frederick C. Kull;Steven Jacobs
通讯作者:
Quynh T. Rohlik;David J. Adams;Frederick C. Kull;Steven Jacobs
影响因子:
39.2
作者:
LEROITH, D;BASERGA, R;ROBERTS, CT
通讯作者:
ROBERTS, CT